Compare RPRX & PKG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RPRX | PKG |
|---|---|---|
| Founded | 1996 | 1867 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Containers/Packaging |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.2B | 17.8B |
| IPO Year | 2020 | 2000 |
| Metric | RPRX | PKG |
|---|---|---|
| Price | $39.74 | $198.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 7 |
| Target Price | $46.00 | ★ $233.43 |
| AVG Volume (30 Days) | ★ 4.3M | 739.3K |
| Earning Date | 11-05-2025 | 10-22-2025 |
| Dividend Yield | 2.21% | ★ 2.52% |
| EPS Growth | N/A | ★ 15.38 |
| EPS | 1.75 | ★ 9.90 |
| Revenue | $2,349,844,000.00 | ★ $8,771,800,000.00 |
| Revenue This Year | $37.13 | $9.43 |
| Revenue Next Year | $1.48 | $13.27 |
| P/E Ratio | $22.68 | ★ $20.05 |
| Revenue Growth | 3.70 | ★ 7.30 |
| 52 Week Low | $24.05 | $172.72 |
| 52 Week High | $41.24 | $245.87 |
| Indicator | RPRX | PKG |
|---|---|---|
| Relative Strength Index (RSI) | 57.50 | 47.80 |
| Support Level | $39.24 | $191.65 |
| Resistance Level | $40.50 | $205.68 |
| Average True Range (ATR) | 0.91 | 4.48 |
| MACD | -0.08 | 0.28 |
| Stochastic Oscillator | 76.02 | 48.31 |
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
Packaging Corp. of America is the third-largest containerboard and corrugated packaging manufacturer in the United States. It produces over 5 million tons of containerboard annually. The company's share of the domestic containerboard market is roughly 10%. PCA differentiates itself from larger competitors by focusing on smaller customers and operating with a high degree of flexibility.